Cryo-Cell International, Inc. Stock Other OTC
Equities
CCEL
US2288951088
Healthcare Facilities & Services
Financials (USD)
Sales 2024 * | 31.78M | Sales 2025 * | 35.21M | Capitalization | 62.57M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 1M | EV / Sales 2024 * | 1.97 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.78 x |
P/E ratio 2024 * |
257
x | P/E ratio 2025 * |
64.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.32% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Jill Taymans
DFI | Director of Finance/CFO | 55 | 97-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Portnoy
CEO | Chief Executive Officer | 61 | 11-07-31 |
Mark Portnoy
CEO | Chief Executive Officer | 60 | 11-07-31 |
Harold Berger
BRD | Director/Board Member | 60 | 11-08-24 |
1st Jan change | Capi. | |
---|---|---|
-14.03% | 86.34B | |
+17.69% | 84.49B | |
+11.97% | 29.68B | |
-9.45% | 17.5B | |
-2.57% | 16.67B | |
-0.99% | 15.18B | |
-4.04% | 12.71B | |
+2.69% | 12.53B | |
-30.53% | 11.89B |